Eli Lilly, Merck, Pfizer and Celgene CEOs Back Republican-Led Tax Reform

Pharmaceutical executives from the nation’s leading firms are urging Congressional leaders to pass a Republican-led tax reform that would allow companies to pay lower taxes.
Source: Drug Industry Daily